CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nucleic Acid Drug Candidates Using Proprietary SiRNA Drug Discovery And Extrahepatic Targeted Delivery Platforms

뉴스 본문을 불러오고 있어요.

CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nucleic Acid Drug Candidates Using Proprietary SiRNA Drug Discovery And Extrahepatic Targeted Delivery Platforms | 웨이프 WAPE

CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nucleic Acid Drug Candidates Using Proprietary SiRNA Drug Discovery And Extrahepatic Targeted Delivery Platforms

기사 요약

관련 종목

댓글 —